Coralie Zumelzu Marina Alexandre Christelle Le Roux Patricia Weber Alexis Guyot Annie Levy Françoise Aucouturier Sabine Mignot-Grootenboer Frédéric Caux Eve Maubec Catherine Prost-Squarcioni
10.3389/fmed.2018.00268
Front Med (Lausanne)
2018 Sep 27;5:268.
adverse drug reaction anti-programmed-death-1/death-ligand-1 bullous pemphigoid drug accountability study immune checkpoints inhibitors melanoma mucous membrane pemphigoid pembrolizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/30320114/
Case Reports
PMC6170650
30320114
Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature
2018